Searched over 200M research papers
10 papers analyzed
These studies suggest that metformin can cause diarrhea due to its effects on gastrointestinal function, including reduced Na+ and water absorption, and higher risk with immediate-release formulations.
20 papers analyzed
Metformin is a widely prescribed medication for managing type 2 diabetes mellitus due to its efficacy in controlling blood glucose levels. However, a significant number of patients experience gastrointestinal side effects, particularly diarrhea, which can be severe enough to necessitate discontinuation of the drug. This article explores the various mechanisms proposed to explain why metformin causes diarrhea.
Diarrhea is a common side effect of metformin, affecting approximately 20% of patients on the drug, compared to only 6% of those not taking it. This adverse effect can occur both at the start of treatment and after prolonged use, with some patients experiencing severe symptoms such as incontinence and soiling of clothes . In a study of patients using extended-release metformin, more than half reported experiencing diarrhea, with an average of 12 episodes per month.
One of the primary mechanisms proposed involves the inhibition of the Na+/H+ exchanger 3 (NHE3), which is crucial for sodium and water absorption in the intestines. Metformin has been shown to decrease NHE3 activity, leading to increased fecal water content and diarrhea. This inhibition is mediated by the activation of 5′-AMP-activated protein kinase (AMPK), which increases the phosphorylation and ubiquitination of NHE3, resulting in its removal from the plasma membrane.
Metformin affects the digestive uptake of bile salts, which can lead to malabsorption and diarrhea. Bile salts are essential for the digestion and absorption of fats, and their malabsorption can result in increased water secretion into the intestines, causing diarrhea.
Another hypothesis suggests that metformin stimulates the intestinal secretion of serotonin, a neurotransmitter that can increase gut motility and fluid secretion, leading to diarrhea.
Research using mouse models has shown that metformin can alter the composition of gut microbiota, particularly reducing the levels of Firmicutes, a group of bacteria associated with gut health. This alteration in gut flora may contribute to the development of diarrhea.
Metformin has been found to increase the expression of the cystic fibrosis transmembrane conductance regulator (CFTR) in the ileum and colon. CFTR is a key ion channel involved in chloride and water transport, and its upregulation can lead to increased water secretion and diarrhea.
Given the high prevalence and potential severity of metformin-induced diarrhea, it is crucial for healthcare providers to recognize this side effect and manage it appropriately. Discontinuation of metformin often resolves the symptoms within a few days . In some cases, switching to an extended-release formulation of metformin may reduce the incidence of gastrointestinal side effects.
Metformin-induced diarrhea is a multifaceted issue involving altered intestinal transport, bile salt malabsorption, increased serotonin secretion, changes in gut microbiota, and increased CFTR expression. Understanding these mechanisms can help in better managing this common side effect, ensuring that patients can continue to benefit from the glucose-lowering effects of metformin without compromising their quality of life.
Most relevant research papers on this topic